Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming catalysts for ...
MedPage Today on MSN15h
New AGA Guideline; Imaging for HCC Surveillance; 'Breakthrough' Hepatitis D DrugResearchers identified the enzyme CMPK2 as a possible target for therapies aiming to prevent metabolic dysfunction-associated ...
Kura Oncology's stock plummeted 50% after announcing a collaboration with Kyowa Kirin, making it a less attractive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback